首页 | 本学科首页   官方微博 | 高级检索  
     


Encephalopathy associated with autoimmune thyroid disease in patients with Graves' disease: clinical manifestations,follow-up,and outcomes
Authors:Gianluca Tamagno  Yahya Celik  Rafael Simó  Marcel Dihné  Kazumi Kimura  Giorgio Gelosa  Byung I Lee  Caroline Hommet  Giovanni Murialdo
Affiliation:1.Department of Endocrinology and Diabetes Mellitus,St Vincent's University Hospital, University College Dublin,Dublin,Ireland;2.Department of Neurology,Trakya University School of Medicine,Edirne,Turkey;3.Division of Endocrinology,Vall d'Hebron University Hospital,Barcelona,Spain;4.Department of Neurology,University Hospital Düsseldorf,Düsseldorf,Germany;5.Department of Stroke Medicine,Kawasaki Medical School,Okayama,Japan;6.Department of Neurology, San Gerardo Hospital,University of Milano-Bicocca,Monza,Italy;7.Department of Neurology, Severance Hospital,Yonsei University College of Medicine,Seoul,South Korea;8.Service of Geriatric Internal Medicine,Regional University Hospital,Tours,France;9.Department of Endocrine and Medical Sciences,University of Genoa,Genoa,Italy
Abstract:

Background  

The encephalopathy associated with autoimmune thyroid disease (EAATD) is characterized by neurological/psychiatric symptoms, high levels of anti-thyroid antibodies, increased cerebrospinal fluid protein concentration, non-specific electroencephalogram abnormalities, and responsiveness to the corticosteroid treatment in patients with an autoimmune thyroid disease. Almost all EAATD patients are affected by Hashimoto's thyroiditis (HT), although fourteen EAATD patients with Graves' disease (GD) have been also reported.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号